General Medicine A
Charlson Comorbidity Index (CCI) — Detailed
Detailed 17-condition comorbidity index predicting 10-year mortality. Age-adjusted version adds 1 point per decade after age 50.
References
- Charlson ME et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
- Quan H et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- ADHERE Algorithm for Acute Decompensated Heart Failure · Risk Stratification
- TIMI Risk Index for STEMI · Risk Stratification
- LACE Index for Readmission Risk · Risk Stratification
- GI-BLEED Score for Upper GI Bleeding · Risk Stratification
- HCT-CI — Haematopoietic Cell Transplant Comorbidity Index · Risk Stratification
- San Francisco Syncope Rule (SFSR) · Risk Stratification
Drugs
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction) · Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
Pathways
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.